Self-infusion of prophylaxis: evaluating the quality of its performance and time needed
| Authors | J. Lock , M.H. Cnossen , M. Beijlevelt-van der Zande , Marieke Schuurmans , M. Peters , L.H. Schrijvers , K. Fischer |
|---|---|
| Published in | Haemophilia |
| Publication date | 2016 |
| Research groups | Chronic Diseases |
| Type | Article |
Summary
Prophylactic replacement therapy is the cornerstone of treatment in severe haemophilia. Regular infusions with clotting factor concentrate have been proven effective to prevent bleeding, subsequent (joint) damage, and positively affect the impact of haemophilia on daily life [1]. Patients or parents of younger patients learn to infuse clotting factor concentrate in a peripheral vein (i.v.) or a central venous access device (CVAD) [2].
| Language | English |
|---|---|
| Published in | Haemophilia |
| Year and volume | 22 3 |
| Page range | e214-e217 |